| Metric | შპს Linema Pharm | შპს ვორლდ ფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾3.9m₾1.6m | ₾4.5m₾2.5m |
| Revenue growth | 139.8% | 83.4% |
| Profitability | ||
| EBITDA | ₾1.2m₾465k | ₾1.8m₾933k |
| EBITDA margin | 31.0%28.7% | 39.6%38.0% |
| Net profit | ₾1.2m-₾90k | ₾1.8m₾778k |
| Net margin | 31.0%-5.5% | 39.6%31.6% |
| Balance sheet | ||
| Total assets | ₾7.5m₾6.2m | ₾4.1m₾1.9m |
| Total equity | ₾6.4m₾5.4m | ₾3.3m₾1.5m |
| ROE | 18.9%-1.6% | 54.8%52.7% |